Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBITDA (2016 - 2025)

Historic EBITDA for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to -$5.4 million.

  • Neogen's EBITDA rose 9882.47% to -$5.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$627.2 million, marking a year-over-year decrease of 4581.37%. This contributed to the annual value of -$1.1 billion for FY2025, which is 190863.07% down from last year.
  • As of Q4 2025, Neogen's EBITDA stood at -$5.4 million, which was up 9882.47% from -$16.1 million recorded in Q3 2025.
  • Over the past 5 years, Neogen's EBITDA peaked at $23.4 million during Q2 2023, and registered a low of -$611.2 million during Q2 2025.
  • Over the past 5 years, Neogen's median EBITDA value was $12.2 million (recorded in 2021), while the average stood at -$44.6 million.
  • In the last 5 years, Neogen's EBITDA soared by 28893.68% in 2023 and then tumbled by 478700.15% in 2025.
  • Quarter analysis of 5 years shows Neogen's EBITDA stood at $12.5 million in 2021, then tumbled by 161.4% to -$7.7 million in 2022, then soared by 288.94% to $14.5 million in 2023, then crashed by 3262.7% to -$457.5 million in 2024, then skyrocketed by 98.82% to -$5.4 million in 2025.
  • Its last three reported values are -$5.4 million in Q4 2025, -$16.1 million for Q3 2025, and -$611.2 million during Q2 2025.